EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tau acetylation at K331 has limited impact on tau pathology in vivo

Shoko Hashimoto iD, Yukio Matsuba, Mika Takahashi, Takaomi C Saido iD

FEBS Letters · 2026-07 · 600 (14) · 2050-2062

DOI: 10.1002/1873-3468.70320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Letters, online erschienen am 10.03.2026. Verfasst von Shoko Hashimoto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pioneering Research Division, Medical Innovation Research Center, Shiga University of Medical Science, Otsu, Shiga, Japan. Hauptthemen laut MEDLINE: tau Proteins. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Co-creation place formation support program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post‐translational modifications regulate tau aggregation and propagation, yet how amyloid pathology shapes the tau modification landscape remains unclear. Using liquid chromatography–tandem mass spectrometry, we compared tau modifications in MAPT knock‐in ( MAPT KI) mice and MAPT / App double knock‐in mice with App NL‐G‐F amyloid pathology. Only subtle differences were detected, with a tendency toward increased acetylation within the repeat domain. Because K321 and K331 lie in the fibril‐forming core, their roles were further examined. Acetylation at these sites was absent in cynomolgus monkey brains. To test functional relevance, we generated acetylation‐mimicking MAPT K331Q knock‐in mice on the MAPT KI background. Despite tau expression, these mice showed reduced tau phosphorylation at 24 months, with unchanged insoluble tau and seeding activity. Thus, K331 acetylation does not promote tau pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsAnimalsAcetylationProtein Processing, Post-TranslationalPhosphorylationMiceBrainMice, TransgenicMacaca fascicularisHumansGene Knock-In TechniquesLysine

Stichwörter der Autor:innen

Alzheimer's diseaseTauacetylationknock‐in mouse modelspost‐translational modifications

Substanzen

tau ProteinsLysine

Autor:innen und Institutionen

  • Pioneering Research Division, Medical Innovation Research Center, Shiga University of Medical Science, Otsu, Shiga, Japan.
  • Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, Wako, Saitama, Japan.

ORCID-Profile: Shoko Hashimoto, Takaomi C Saido

Förderung

  • Japan Society for the Promotion of Science
  • Co-creation place formation support program

Zitieren

APA

Hashimoto, S., Matsuba, Y., Takahashi, M., & Saido, T. C. (2026). Tau acetylation at K331 has limited impact on tau pathology in vivo. FEBS Letters, 600(14), 2050-2062. https://doi.org/10.1002/1873-3468.70320

Vancouver

Hashimoto S, Matsuba Y, Takahashi M, Saido TC. Tau acetylation at K331 has limited impact on tau pathology in vivo. FEBS Letters. 2026;600(14):2050-2062. doi:10.1002/1873-3468.70320

BibTeX
@article{Hashimoto2026,
  author = {Hashimoto, Shoko and Matsuba, Yukio and Takahashi, Mika and Saido, Takaomi C},
  title = {Tau acetylation at K331 has limited impact on tau pathology in vivo},
  journal = {FEBS Letters},
  year = {2026},
  volume = {600},
  number = {14},
  pages = {2050--2062},
  doi = {10.1002/1873-3468.70320}
}
Kostenlos starten →